GPT-Rosalind (OpenAI) vs GPT-5.4-Cyber (OpenAI)

GPT-5.4-Cyber (OpenAI) edges out GPT-Rosalind (OpenAI) by 0.4 points (7.2 vs 6.8) -- a B-tier vs C-tier split that's narrow but real. Not a blowout; both belong on a shortlist. The score gap shows up most clearly in the categories that matter for GPT-5.4-Cyber (OpenAI)'s strengths, so if those categories are your priority, the lead translates.

Neither tool offers a free tier. GPT-Rosalind (OpenAI) starts at Invite only, GPT-5.4-Cyber (OpenAI) at Not publicly disclosed. Plan to budget for whichever you pick. The cheap tier usually caps out faster than buyers expect, so look at what the entry plan actually includes -- both vendors have raised list prices in 2026 and the limits are where most of the cost surprise lives.

By use case: pick GPT-Rosalind (OpenAI) when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access. Pick GPT-5.4-Cyber (OpenAI) when enterprise soc teams, established security research orgs, and vetted individual defenders who can qualify for trusted access for cyber. The two tools aren't fighting for the same person -- they're aiming at adjacent jobs that occasionally overlap. If you're squarely in GPT-5.4-Cyber (OpenAI)'s lane, the tier-list ranking and the use-case fit point the same direction; if you're in GPT-Rosalind (OpenAI)'s lane, the score gap matters less than the fit.

Bottom line: GPT-5.4-Cyber (OpenAI) is the safer default for most readers, but GPT-Rosalind (OpenAI) is competitive enough that the tie-breaker is your specific workload, not the spec sheet.